Literature DB >> 24630990

S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3.

Saul J Priceman1, Shudan Shen1, Lin Wang1, Jiehui Deng1, Chanyu Yue1, Maciej Kujawski2, Hua Yu3.   

Abstract

S1PR1 signaling has been shown to restrain the number and function of regulatory T (Treg) cells in the periphery under physiological conditions and in colitis models, but its role in regulating tumor-associated T cells is unknown. Here, we show that S1PR1 signaling in T cells drives Treg accumulation in tumors, limits CD8(+) T cell recruitment and activation, and promotes tumor growth. T-cell-intrinsic S1PR1 affects Treg cells, but not CD8(+) T cells, as demonstrated by adoptive transfer models and transient pharmacological S1PR1 modulation. An increase in S1PR1 in CD4(+) T cells promotes STAT3 activation and JAK/STAT3-dependent Treg tumor migration, whereas STAT3 ablation in T cells diminishes tumor-associated Treg accumulation and tumor growth. Our study demonstrates a stark contrast between the consequences of S1PR1 signaling in Treg cells in the periphery versus tumors.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24630990      PMCID: PMC3988983          DOI: 10.1016/j.celrep.2014.02.016

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  31 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Regulatory T cells in immune surveillance and treatment of cancer.

Authors:  Tomoyuki Yamaguchi; Shimon Sakaguchi
Journal:  Semin Cancer Biol       Date:  2006-01-11       Impact factor: 15.707

Review 3.  Regulatory T cells, tumour immunity and immunotherapy.

Authors:  Weiping Zou
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

Review 4.  Regulation of the roles of sphingosine 1-phosphate and its type 1 G protein-coupled receptor in T cell immunity and autoimmunity.

Authors:  Edward J Goetzl; Jia-Jun Liao; Mei-Chuan Huang
Journal:  Biochim Biophys Acta       Date:  2008-03-12

Review 5.  Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Authors:  Hua Yu; Marcin Kortylewski; Drew Pardoll
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

6.  Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes.

Authors:  Markus H Gräler; Mei-Chuan Huang; Susan Watson; Edward J Goetzl
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

7.  Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer.

Authors:  Aoshuang Chen; Shanrong Liu; David Park; Youmin Kang; Guoxing Zheng
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.

Authors:  Jean-René Pallandre; Emilie Brillard; Gilles Créhange; Amandine Radlovic; Jean-Paul Remy-Martin; Philippe Saas; Pierre-Simon Rohrlich; Xavier Pivot; Xiang Ling; Pierre Tiberghien; Christophe Borg
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

9.  miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.

Authors:  Jun Wei; Fei Wang; Ling-Yuan Kong; Shuo Xu; Tiffany Doucette; Sherise D Ferguson; Yuhui Yang; Kayla McEnery; Krishan Jethwa; Olsi Gjyshi; Wei Qiao; Nicholas B Levine; Frederick F Lang; Ganesh Rao; Gregory N Fuller; George A Calin; Amy B Heimberger
Journal:  Cancer Res       Date:  2013-05-01       Impact factor: 12.701

10.  Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.

Authors:  Mitsugu Fujita; Xinmei Zhu; Kotaro Sasaki; Ryo Ueda; Keri L Low; Ian F Pollack; Hideho Okada
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

View more
  41 in total

1.  STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

Authors:  Chunyan Zhang; Chanyu Yue; Andreas Herrmann; Jieun Song; Colt Egelston; Tianyi Wang; Zhifang Zhang; Wenzhao Li; Heehyoung Lee; Maryam Aftabizadeh; Yi Jia Li; Peter P Lee; Stephen Forman; George Somlo; Peiguo Chu; Laura Kruper; Joanne Mortimer; Dave S B Hoon; Wendong Huang; Saul Priceman; Hua Yu
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

Review 2.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

Review 3.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

Review 4.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

5.  STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.

Authors:  Chanyu Yue; Shudan Shen; Jiehui Deng; Saul J Priceman; Wenzhao Li; Austin Huang; Hua Yu
Journal:  Cancer Immunol Res       Date:  2015-05-29       Impact factor: 11.151

6.  Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition.

Authors:  Anthony S Fischl; Xiaoen Wang; Beverly L Falcon; Rowena Almonte-Baldonado; Diane Bodenmiller; Glenn Evans; Julie Stewart; Takako Wilson; Philip Hipskind; Jason Manro; Mark T Uhlik; Sudhakar Chintharlapalli; Damien Gerald; David C Alsop; Laura E Benjamin; Rupal S Bhatt
Journal:  Mol Cancer Ther       Date:  2019-02-20       Impact factor: 6.261

Review 7.  Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker.

Authors:  Zhengyi Wang; Xiaoying Wu
Journal:  Cancer Med       Date:  2020-09-02       Impact factor: 4.452

Review 8.  Sphingosine kinase 1 in breast cancer.

Authors:  Kurt Geffken; Sarah Spiegel
Journal:  Adv Biol Regul       Date:  2017-10-16

9.  Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.

Authors:  Qi Lin; Ye Wei; Yunshi Zhong; Dexiang Zhu; Li Ren; Pingping Xu; Peng Zheng; Qingyang Feng; Meiling Ji; Minzhi Lv; Chunmin Liang; Jianmin Xu
Journal:  Tumour Biol       Date:  2014-06-28

10.  miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.

Authors:  Nan Cheng; Guang-Hui Wang
Journal:  Exp Ther Med       Date:  2016-02-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.